Patent directory · USPTO A61K / A61P
Patents matching “Ultragenyx Pharmaceutical Inc.”
23 pharma patents match "Ultragenyx Pharmaceutical Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 23 pharmaceutical patents matching "Ultragenyx Pharmaceutical Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12358976
Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d
granted -
US 12338450
Gene therapy constructs for treating Wilson disease
granted -
US 11944658
Methods of heat inactivation of adenovirus
granted -
US 11771748
Methods for treating tumor-induced osteomalacia
granted -
US 11753369
Creatine prodrugs, compositions and methods of use thereof
granted -
US 11377643
Therapeutics for glycogen storage disease type III
granted -
US 11332438
Creatine prodrugs, compositions and methods of use thereof
granted -
US 11202822
Methods for treating hypophosphatemic disorders
granted -
US 11013774
Methods of heat inactivation of adenovirus
granted -
US 10889607
Sialic acid analogs
granted -
US 10639360
Methods for treating hypophosphatemic disorders
granted -
US 10457701
Sialic acid analogs
granted -
US 10385085
Crystal forms of sialic acid or salt or solvate thereof
granted -
US 10065981
Sialic acid analogs
granted -
US 9937243
Sialylated glycoprotein compositions and uses thereof
granted -
US 9687532
Sialylated glycoprotein compositons and uses thereof
granted -
US 9554987
Methods and formulations for treating sialic acid deficiencies
granted -
US 9511015
Methods and formulations for treating sialic acid deficiencies
granted -
US 9457067
Sialylated glycoprotein compositions and uses thereof
granted -
US 9457068
Sialylated glycoprotein compositions and uses thereof
granted -
US 9241896
Methods and formulations for treating sialic acid deficiencies
granted -
US 9221858
Sialic acid analogs
granted -
US 8840926
Sialic acid analogs
granted